This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: Schlumberger Technology Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Juan Alvarez - Innovator in Biopharmaceuticals
Introduction
Juan Alvarez is a notable inventor in the field of biopharmaceuticals, currently based in the United States. He has made significant contributions to the development of innovative compounds and polypeptides that enhance biological functions. Although he holds no patents at this time, his work continues to influence the industry.
Latest Patents
Juan Alvarez's latest patents include "Ligands Modified By Circular Permutation As Agonists And Antagonists." This invention provides fusion polypeptides that comprise polypeptide ligands modified by circular permutation. These ligands are fused to at least one polypeptide fusion partner, resulting in fusion polypeptides with new, improved, or enhanced biological functions. The improvements include increased binding affinity, increased activity, and enhanced agonist and antagonist activities, among others. Another notable invention is "Prodrugs Of Tertiary Amine Compounds," which relates to compounds of Formula (I).
Career Highlights
Juan Alvarez is currently employed at Alkermes Pharma Ireland Limited, where he applies his expertise in biopharmaceutical innovation. His work focuses on developing advanced therapeutic solutions that address various medical needs.
Collaborations
Juan has collaborated with several talented individuals in his field, including Jean Chamoun and Laura Cook Blumberg. These collaborations have contributed to the advancement of his research and the development of innovative solutions in biopharmaceuticals.
Conclusion
Juan Alvarez is a dedicated inventor whose work in biopharmaceuticals showcases his commitment to enhancing medical therapies. His innovative approaches and collaborations continue to pave the way for future advancements in the industry.